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Abstract
Background: The ability of living cells to respond appropriately to apoptosis signals is crucial for the proper
development and homeostasis of multicellular organisms. For example, viable cells must be stable enough to
appropriately respond to apoptosis signaling so that an irreversible death program is only induced when apoptosis
signaling reaches a certain threshold. Previous studies have introduced bistability models in which signaling by
caspase-3 activity represents a key regulator of cell fate in response to apoptosis stimuli.
Results: In this study, apoptosis induced by tumor necrosis factor (TNF) signaling is investigated, and a
mathematical model without the requirement for bistability is proposed. In this model, rapid degradation of the
active forms of caspases -8 and -3 are included, and TNF-signaling is found to induce a pulse of caspase-3
activation and trigger an irreversible death program. This result agrees with experimental observations. The ability
of a cell to respond to, or resist, apoptosis stimuli is also discussed. Furthermore, the activation efficiencies of
caspases -8 and -3 that are essential to a cell’s response to extracellular apoptosis stimuli are defined. Based on the
simulations performed, it is observed that activation efficiencies must be sufficiently sensitive to appropriately
compromise a cell’s resistance and effectiveness in response to apoptosis stimuli.
Conclusions: Our results suggest that bistability may not be a necessary condition for the induction of apoptosis
by TNF signaling. Rather, a sharp increase in caspase-3 activity might be sufficient to trigger the induction of an
irreversible death program. Accordingly, regulation of caspase activity and degradation of active caspases is
essential for a cell’s response to apoptosis stimuli.
Background
Apoptosis is a genetically programmed cell death event
that is crucial for development, tissue homeostasis, and
the immune response of multicellular organisms [1].
Correspondingly, defects in apoptosis can result in a
number of serious diseases including cancer, autoimmu-
nity, and neurodegeneration. Cells exist in either a ‘sur-
vival’ state or are undergoing apoptosis, depending on
their response to apoptosis [2]. In a ‘survival’ state, cells
a r es t a b l ea n dr e s i s t a n tt o w ards low levels of apoptosis
signaling. In contrast, cells undergo apoptosis that
involves the initiation of an irreversible signaling
pathway when apoptosis signals exceed a certain thresh-
old. Nevertheless, the means by which cells determine
their fate (i.e., survival or death) based on signaling
activity is not well understood.
There are two pathways known to trigger apoptosis:
an intracellular pathway that is initiated when the cell is
severely damaged or stressed, and a signaling pathway
that is induced when extracellular death ligands are
bound by their cognate membrane-associated death
receptors [3]. Furthermore, the central mediators of the
apoptosis pathways includes a set of cysteine proteases
that are part of a large protein family known as cas-
pases. In recent years, several important caspases have
been identified. In particular, caspase-8 has been identi-
fied as a key initiator of the death-receptor pathway,
and caspase-3 is an executioner of apoptosis wherein
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an active site cysteine which can cleave the Asp-Xxx
bonds of several target substrates. However, caspases are
initially synthesized as enzymatically inert zymogens. To
activate caspases, pro-caspases are proteolytically cleaved
by upstream caspases (as is the case for caspase-3, -6, and
-7), are activated by induced proximity (caspase-8), or are
activated by holoenzyme formation (caspase-9) [3].
The tumor necrosis factors (TNF) family of proteins is
a group of cytokines that can induce apoptosis [4].
Known TNF family members include TNF-a,T N F - b,
Fas(CD95/Apo-1) ligand, and TRAIL (TNF-related
apoptosis-inducing ligand), to name a few. TNF acts via
the TNF receptor (TNF-R) to trigger apoptosis.
Furthermore, TNF-R is associated with pro-caspases
through adapter proteins such as Fas-associated protein
with death domains (FADD) and TNF-R-associated
death domains (TRADD), resulting in the activation of
caspase cascades that can irreversibly commit a cell to
apoptosis [5]. Upon stimulation of TNF ligand, adapter
proteins aggregate and form membrane-bound death
signaling complexes. These death-inducing signaling
complexes (DISCs) recruit and activate the pro-caspase-
8 which undergoes proteolytic cleavage as part of this
process [3]. Activated caspase-8 usually exists as a dim-
mer, and upon release from DISCs into the cytoplasm,
activated caspase-8 is capable of inducing downstream
signaling that results in the production of activated cas-
pase-3 from cleavage of pro-caspase-3. For this process,
there are two different pathways [6]. For example, in
cells known as type I, a large amount of caspase-8 is
released from DISCs which rapidly and directly cleaves
caspase-3. In type II cells, activation of caspase-8 results
in a signal that is amplified via a mitochondria pathway
to induce activation of caspase-9, which then cleaves
pro-caspase-3. The resulting activation of caspase-3 then
triggers an irreversible cell death program in the nucleus
[3,7], and this involve the inactivation of PARP and
DNA-PK, two key enzymes involved in the homeostatic
maintenance of genomic integrity [8,19].
Many efforts have been made to quantitatively study
the process of cell fate determination in relation to the
simulation of apoptosis [2,9-15]. In studies by Hua et al.
[12], a computational model for the Fas-signaling path-
way was developed (hereinafter referred to as the
HCCSL model, also refer to reference [14] for a corre-
sponding minimal model). This model integrated data
currently available regarding signaling networks down-
stream of Fas activation, including both type I and type
II pathways, up until activation of caspase-3. The main
drawback of the HCCSL model is that degradations of
activated caspases -8 and -3 are not considered. Conse-
quently, the HCCSL model predicts that the caspase
activities should be saturated after prolonged
stimulation, even when Fas signaling is very weak.
However, these results are not consistent with experi-
mental observations where the activity of caspases -8
and -3 decrease after reaching a maximal value
[10,16-18] (to be detailed below). In studies by Bentele
et al. [10], a mathematical model was used to study
CD95-induced apoptosis in type I cells. Using model
predictions and experimental data, a threshold mechan-
ism was identified in which apoptosis fails to be initiated
if ligand concentrations fall below a critical level. More-
over, this threshold was highly sensitive to the concen-
tration of c-FLIP, an inhibitor of caspase-8 activation
and Fas-mediated apoptosis. However, the basis of this
threshold remain unclear.
Bistability may be one reason for the existence of such
a threshold [2]. Several models have been proposed to
explain the bistability properties associated with apopto-
sis signaling pathways [2,9,13]. In these models, the
co-existence of steady states involving the capacity for
low or high levels of caspase-3 activity are presumed to
be an “essential condition” [2]. Moreover, a positive
feedback loop involving caspase-3 activation, with a role
for inhibitors of apoptosis (IAP) proteins, is hypothe-
sized to be essential for such a bistability [2,15]. Never-
theless, to the best of our knowledge, no experimental
evidence directly supports this hypothesis. There have
been experiments which show a peak of caspase-3 activ-
ity following exposure to apoptotic stimuli, and this
level of caspase-3 activity is not the same as the steady
state level. For example, Bentele et al. [10] demonstrated
that simulation of the human B lymphoblastoid cell line
SKW 6.4, with 5µg/mol anti-APO-1, resulted in a rapid
increase in concentration of cPARP, a reporter of active
caspase-3. cPARP concentrations reached their maximal
level after 20 min, after which they steadily decreased
over 3 h. In contrast, when high concentration of ligand
were used in parallel assays, no significant increases in
caspase-3 activity were detected after 24 h of stimulation
[10]. In mouse mammary MOD cells, p53-induced
apoptosis resulted in the activation of caspase-3 after 6
h at 30°C, with activation of caspase-3 reaching maximal
levels after 12 h [16]. At this latter timepoint, a drop in
colony formation was also observed. Similar temporal
kinetics were also observed for human Jurkat cells
where levels of cleaved caspase-3 began to increase 2 h
after the addition of anti-Fas, and then reached a maxi-
mum level by 4 h [17]. These results suggest that cell
fate may be determined by a sudden peak in caspase-3
activity, referred to as a ‘pulse’, rather than its steady
state levels. If this is the case, then bistability is not an
“essential condition” for the apoptosis pathway.
Tawa et al. reported that the rapid degradation of
active caspase-3 is dependent on the catalytic activity of
caspase-3 [18]. Using a mathematical model, Stucki et
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3 may be particularly relevant to long-living cells [15].
For the HCCSL model [12], the rapid clearance of
actived caspase-3 after being induced by apoptosis sig-
naling was not considered, but however, could be an
important factor for the pulse increase in caspase-3
activity that has been detected.
This study investigates apoptosis induced by extracellu-
lar signaling using a mathematical model that excludes
bistability as a prerequistite. The mathematical model
used is based on the HCCSL model, yet accounts for the
rapid degradation of activated caspases -8 and -3. More-
over, this study is intended to address one aspect of cell
fate determination, particularly the predominant signaling
mediated by caspase-8 as an initiator and caspase-3 as an
executioner, instead of comprehensively modeling apopto-
sis signal pathways. Despite the restricted nature of this
investigation, our model shows fair agreement with experi-
mental results, both qualitatively and quantitatively. As a
result, we are able to study the temporal behavior of
caspase-3 activity upon stimulation of apoptosis, and
explicitly define the activation efficiencies of caspases -8
and -3, which are essential for a cell’sr e s p o n s et oe x t r a c e l -
lular apoptosis stimuli.
Model and Methods
Model structure and formulations
Figure 1 illustrates the apoptosis pathway being studied
and the role for TNF-signaling. The main constituents
were adapted from a Fas-signaling model previously
established [12,14]. Upon binding of the TNF receptor
(TNF-R) by TNF ligand (TNF), adapter proteins aggre-
gate to form DISCs. These complexes then recruit and
cleave pro-caspase-8 to generate active caspase-8, which
in turn induces the cleavage of pro-caspase-3, either
directly (in type I cells) or indirectly via mitochondria
(in type II cells) [6]. In type I cells, a high concentration
of caspase-8 is released from DISCs and directly cleaves
TNF ligand
TNF-R
FADD
Pro-
Caspase8
FLIP
Caspase8
Caspase3
Pro-
Caspase3
Caspase9
Procaspase9
Procaspase9
Apaf-1
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Figure 1 A model for TNF signaling-induced apoptosis An illustrated model of apoptosis induced by TNF signaling. TNF signaling induces
the formation of membrane-bound death inducing signaling complexes (DISC), which subsequently recruit pro-caspase-8 and activate it by
proteolytic cleavage. The active caspase-8 then cleaves various intracellular proteins, including pro-caspase-3, which results in caspase-3
activation and triggering of the cell death program. Caspase-8 cleavage of caspase-3 can occur through two separate pathways, either directly or
indirectly, via mitochondria and caspase-9.
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downstream signaling to the apoptosis pathway. Alterna-
tively, in type II cells, caspase-8 signaling is amplified via
mitochondria and pro-caspase-9 which results in the
cleavage of pro-caspase-3. The latter amplification path-
way includes the following main steps: activated cas-
pase-8 enzymatically cleaves Bid to generate tBid. tBid is
then associated with two Bax proteins (i.e., tBid:Bax2)
and ‘activates’ mitochondria to release pro-apoptotic
molecules such as cytochrome c and Smac/DIABLO.
Once released, cytochrome c associates with Apaf-1
(Apaf) and pro-caspase-9 to form an apoptosome, the
second initiator complex of apoptosis. The apoptosome
generates active caspase-9 which then cleaves pro-
caspase-3 to produce activated caspase-3.
In the following mathematical model, not every reac-
tion was modeled. Instead, the time course of initiator
protein concentrations (i.e., TNF receptor, caspase-8)
and executor concentrations (i.e., caspase-3) of the
apoptosis pathway will be focused on. Accordingly,
there are five main components in our model, [TNF-R],
[Casp8], [Casp3], Casp82
* ⎡
⎣
⎤
⎦ and [Casp3*], which repre-
sent the concentrations of bound TNF receptor, pro-
caspase-8, pro-caspase-3, active caspase-8 and active
caspase-3, respectively. The concentrations of both pro-
caspases and active caspases are expected to exist in a
steady state prior to the onset of the apoptosis signal.
When TNF ligands are released and bind to their cog-
nate receptors, downstream signaling is hypothesized to
be affected by the stimulus, synthesis, degradation, and
cleavage of pro-caspases. The time course of this
process is modeled using the following set of differential
equations
dd t V V
dd t V V
TNF-R
Casp
on
TNF-R
off
TNF-R
syn
Casp8
act
C
[] =−
[] =−
/
/ 82
a asp8 Casp8
act
Casp8
deg
Casp8 Casp
Casp3
−
⎡
⎣
⎤
⎦ =−
V
dd t V V
d
deg
* /
*
82
2
[ [] =−−−
[
/ d t VVVV
d
syn
Casp3
act,D
Casp3
act,M
Casp3
deg
Casp3
Casp3*] ] =+− / dt V V V act,D
Casp3
act,M
Casp3
deg
Casp3*
(1)
Here, V’s represent molecule fluxes and are listed in
Table 1. Detailed explanations of the fluxes involved are
given below.
In the above model, the equation for [TNF-R] is not
essential for the apoptosis pathway, and is included only
to reproduce the delay of caspase-8 activation that has
been observed in experimental data (Fig. 3A). Further-
more, the coefficient 2 in the second equation is based
on the dimerization of active caspase-8 that occurs.
The activation of caspase-8 is a complicated process
that requires DISCs. For example, in the case of Fas-sig-
naling induced apoptosis, these processes are composed
of many reactions that include the recruitment of
FADD, the binding of FADD to Fas receptor, the bind-
ing of FLIP or pro-caspase-8 to an adapter protein, and
the generation of an intermediate cleavage product
Casp82: p41 [14]. Our model does not encompass the
comprehensive scope of all of the reactions listed above.
Instead, we have simplified these processes according to
the state of DISCs, which is characterized by the
Table 1 Rate expressions and parameters
Rate Rate expression Parameters
Association of TNF to the receptor TNF-R, Von
TNF-R
Vk on
TNF-R
on TNF TNF-R TNF-R = [] [ ] −[] () 0
kon = 9.09 × 10
-5 nM
-1s
-1
Dissociation of TNF, Voff
TNF-R Vk off
TNF-R
off TNF-R = [] koff= 1.00 × 10
-4s
-1
Activation of Casp8 through DISC, Vact
Casp8 V
v
KK
act
Casp8 TNF-R Casp
Casp8 Casp
= [] [ ]
+ [] + []
1
2
1
2
2
2
8
8
v1 = 2.65 × 10
-3s
-1
K1 = K2 = 50nM
Activation of Casp3 directly, Vact,D
Casp3 Vv act,D
Casp3 Casp Casp = ⎡
⎣
⎤
⎦[] 22 83
* v2 = 6.00 × 10
-5nM
-1s
-1
Activation of Casp3 through mitochondria, Vact,M
Casp3 Vv
K
act,M
Casp3 Casp Casp
Casp
Casp =
[] ⎡
⎣
⎤
⎦
+ ⎡
⎣
⎤
⎦
[] 3
0 2
32
98
8
3
*
*
t
t
v3 = 2.60 × 10
-4s
-1
[Casp9]0 = 20nM
K3 = 8nM
τ = 30min
Synthesis rate V
x
syn Vv
x
x syn = vCasp8 = 6.67 × 10
-4nMs
-1
vCasp3 = 4.00 × 10
-5nMs
-1
Degradation rate V
x
deg Vd X
x
x deg = dcasp8 = 2.00 × 10
-5s
-1
ds Casp82 34 0 1 0
31
* . =×
−−
dcasp3 = 2.00 × 10
-7s
-1
dCasp3* = 2.40 × 10
-4s
-1
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Page 4 of 10number of pro-caspase-8 molecules present in each
complex (Fig. 2). We omitted the states with three pro-
caspase-8 molecules since DISCs can rapidly release
activated caspase-8 dimers, thereby making the popula-
tion of DISCs that are associated with three pro-cas-
pase-8 molecules negligible. Furthermore, the reaction
rate Vact,D
Casp8, as shown in Table 1, is obtained based on
the assumption of quasi-equilibrium for the intermedi-
ate complexes DISCi. Here, the maximum number of
DISCs is limited by the number of TNF receptors.
We assume a first order reaction whereby pro-cas-
pase-3 is cleaved by caspase-8 in accordance with [14].
Similarly, the cleavage of pro-caspase-3 by caspase-9 is
also considered to be a first order reaction. The activa-
tion of caspase-9 is usually induced by caspase-8 via
mitochondria, and the detailed reactions of this pathway
are omitted. They are replaced by a simplified assump-
tion that caspase-9 activity depends on caspase-8 activity
through a Michaelis-Menten type function. A delay, τ,i s
also introduced to represent the lag time needed to
complete intermediate reactions mediated by the mito-
chondria. In the present model, τ = 30min for type II
cells according to [6].
Molecule synthesis and degradation rates are
assumed to be constants. Furthermore, the degradation
rates of the active form of the caspases involved are
assumed to be 2-3 orders larger than those of their
inactive forms.
Parameters used in the present study are listed in Table
1, with most parameter values obtained from [14], and
minor adjustments made due to the model modification
and are summarized below. The synthesis rates, vX,a c t i -
vation rates, vi, degradation rates, dX, and coefficients Ki
are determined by fitting the model simulation to experi-
mental data from human Jurkat cells treated with 100ng/
mol FasL (Fig. 3). The delay, τ, based on [6], while other
parameters were taken from [14]. The association and
dissociation rates between ligand and receptor were
based on [12], which describes Fas-signaling-induced
apoptosis. These parameters could be modified to
account for different types of ligands.
In our simulations, the initial conditions are assumed
to be at steady state prior to the onset of stimuli (i.e.,
[TNF] = 0). Thus, [Casp8] = 33.33nM, [Casp3] =
200.00nM, and TNF-R Casp8 Casp3* [] = ⎡
⎣
⎤
⎦ = [] = 2 0
*
as initial conditions [12].
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Figure 3 Model simulation results for caspase activities Model simulation results for pro-caspase-8 (A), pro-caspase-3 (B), caspase-8 (C) and
caspase-3(D). In (A) and (B), the experimental data (circle dots) are retrieved from [12], Fig. 3, which include time courses for pro-caspase-8 and
-3 in Jurkat cells in the presence of 100ng/ml FasL at room temperature. In the simulation, [TNF] was set to 2.0nM to mimic the stimuli
associated with 100ng/ml FasL [12]. The total concentration of FasL receptor was also set to [TNF-R]0 = 10.0nM according to [12].
Figure 2 A simplified model of caspase-8 activation via DISC In
this model, DISCi represents DISC with (i) number of pro-caspase-8
molecules.
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Page 5 of 10In comparison with the original HCCSL model, two
main simplifications have been applied in the current
model. First, components of the reactions involved in the
formation of DISCs were simplified, and are only repre-
sented by the relation between the output flux of activated
caspase-8 dimers and input stimuli signals. The second
simplification was to represent the amplification pathway
mediated by mitochondria as the response of caspase-9
activity to caspase-8 dimer concentration, while having a
delay to incorporated to represent the total time required
by the intermediate steps. With these simplifications, we
are able to reduce the original 35 variable equations to the
current model of 5 independent values, and thereby repro-
duce the same dynamics as the HCCSL model (Fig. 3).
Caspase-3 activity and cell apoptosis rate
Caspase-3 has been well-characterized as an executioner
of apoptosis, by cleaving and inactivating PARP and
DNA-PK, two enzymes that have been identified to have
key roles in the homeostatic maintenance of genomic
integrity [7,8,19]. Previous experiments have demon-
strated that a pulse increase in caspase-3 activity is
induced following exposure to apoptosis stimuli. For
example, when the human B lymphoblastoid cell line,
SKW6.4, was stimulated with 5µg/mol of anti-APO-1,
caspase-3 activity peaked, and then decreased [10]. In
p53-induced apoptosis, irreversible apoptosis occurs
even when caspase-3 activity is shown to be decreasing
[20], yet the early stages of apoptosis are reversible [16].
In combination, the above observations suggest that
the rate of cell apoptosis depends on temporal activation
of caspase-3. Therefore, we propose the following
formulation to represent the apoptosis rate
rr p K d s
n n n
t
t
d
apop Casp3* Casp3* =+ []+ [] ( )
− ∫ 04 /.
t
(2)
Here, r0 is the basal apoptosis rate in the absence of
executioner caspase-3, and τd is the effective time of cas-
pase-3. The Hill type function is used to represent the
instant role of caspase-3. The basic assumptions for Eq. 2
are: (1) the downstream apoptosis signaling is triggered
when caspase-3 activity exceeds a threshold, K4,a n d( 2 )
the effect of caspase-3 is cumulative. Accordingly, it is
straightforward to have the following equation for the
number of surviving (S) and apoptotic (A) cells,
dS/dt = rproS — rapop(t)S, dA/dt = rapop(t)S, S(0) = S0,
A(0) = 0. (3)
Here rpro is the proliferation rate (assumed to be a
constant). The percentage of apoptotic cells is
fa(t)=A(t)/(S(t)+A(t)), (4)
and can be measured by flow cytometry. Therefore,
the parameters in Eq. 3 can be determined by fitting fa
(t) to experimental data.
Caspase activation efficiency
Here we define the activation efficiencies for caspase-8
and -3, respectively, to measure their ability to generate
active forms of caspase-8 and -3 in response to TNF
stimuli.
First, we write down the variance equation when
[TNF] = 0. Note that when [TNF] = 0, we have
TNF-R Casp8 Casp3*
Casp8 Casp8 Casp3 Ca
[] = ⎡
⎣
⎤
⎦ = [] =
[] = [] [] =
2
0
0
* ,
,s sp3 [] 0
(5)
at steady state. Let δX to be the partial derivative (∂X/
∂[TNF])|[TNF]=0. Performing partial derivative to Eq. 1
with respect to [TNF], and setting [TNF] = 0, we obtain
following variance equation
dd t k k
dd t V
dd
d
TNF-R TNF-R TNF-R
Casp8
on off
act
C
[] = [] − []
[] =− ∂
/
/
0
2
a asp8
TNF-R Casp8 TNF-R TNF-R Casp8
Casp8
/|
*
∂[] () [] − [] [] =0
2
dd
d
d
d ⎡ ⎡
⎣
⎤
⎦ =∂ ∂ [] () [] − [] = // | * dt V d act
Casp8
TNF-R Casp8 TNF-R TNF-R 0 2 dd C Casp8
Casp3 Casp8 act
Casp3
Casp8
2
2
2
*
* // |
⎡
⎣
⎤
⎦
[] =− ∂ ∂⎡
⎣
⎤
⎦ ( ) dd t V d * *
*
/
⎡
⎣
⎤
⎦=
⎡
⎣
⎤
⎦ − []
[] =∂
0 2 3 dd
d
Casp8 Casp
Casp3*
Casp3
act
Casp
d
dd t V
3 3
Casp8 Casp3* Casp8 Casp8 Casp /| *
**
* ∂ ⎡
⎣
⎤
⎦ ( ) ⎡
⎣
⎤
⎦ − ⎡
⎣
⎤
⎦= 2 0 2
2
3 dd d [ [] .
(6)
Here, VVV act
Casp3
act,D
Casp3
act,M
Casp3 =+ represents the total
flux of caspase-3 activation. Setting the left hand side of
Eq. 6 to zero, and solving for the steady state gives the
following
d
d
TNF-R TNF-R
Casp8 T Casp8 act
Casp8
[] = []
⎡
⎣
⎤
⎦ = ( ) ∂∂
0 0
2 1
2
/
//
*
*
K
dV N NF-R TNF-R
Casp3*
TNF-R
Casp3* act
Casp3
[] () []
[] = () ∂
[] = |
/
0
1
d
d dV / /| ,
**
* ∂ ⎡
⎣
⎤
⎦ ( ) ⎡
⎣
⎤
⎦ ⎡
⎣
⎤
⎦= Casp8 Casp8
Casp8 2 0 2
2
d
(7)
where K0 = kon/koff represents the dissociation
constant of the apoptosis ligand-receptor complex. The
variances d Casp82
* ⎡
⎣
⎤
⎦ and δ[Casp3*] given above mea-
sure the changes in levels of active caspases, and these
are closely related to the resistance properties of a cell.
Accordingly, the activation efficiencies of caspase-8 and
-3 can be defined respectively as the coefficients in
d Casp82
* ⎡
⎣
⎤
⎦ and δ[Casp3*] of Eq. 7 as follows:
Ad V Casp8 Casp8 act
Casp8
TNF-R TNF-R = ( ) ∂∂ [] () [] = 1
2 0 // | , * (8)
and
Ad V Casp3 Casp3* act
Casp3
Casp8 Casp8 = () ∂∂ ⎡
⎣
⎤
⎦ ( ) ⎡
⎣
⎤
⎦= 1 2 0 2
// | .
*
* (9)
Then, using Vact
Casp8 and Vact
Casp3 in the present model:
Ad v K K Casp8 Casp8 Casp8 Casp8 Casp8 = ( ) [] + [] + [] ( ) ( 1
2 1 0
2
1
2
2 00
2 // * ) ), (10)
Ad v v K Casp3 Casp3* Casp9 Casp3 = () + [] () [] 1 23 0 3 0 // . (11)
Biologically, the activation efficiency ACasp8 measures
the marginal effect the apoptosis ligand-receptor
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sures the marginal effect of caspase-8 on caspase-3
activation.
Results and Discussion
Caspase-3 activity exhibits pulse increase in response to
apoptosis stimuli
The time courses of the concentration of pro-caspases
and active caspases were monitored in our simulation
for 10 h (Figure 3). A time-dependent reductions in
levels of pro-caspase-8 and -3 were detected (Fig. 3,
A&B), as well as the time course for caspase-8 and -3
activation (Fig. 3, C&D). In the latter case, both acti-
vated caspases exhibited a pulse increase in activity
which reached a maximum level after approximately 2
h, and then decreased to low levels. These results agree
qualitatively with previously reported experimental
results [6,17,21], and this simulation reveals that the
maximum level of activated caspase-8 occurs at low
saturation (i.e., at ~ 2.8% of the maximum pro-caspase-
8 concentration). We hypothesize that this is based on a
reduction in DISC formation, as previously shown in
type II cells [6]. In contrast, caspase-3 activity reaches
its maximum at ~ 40% saturation approximately 30 min
after caspase-8 reached its maximal level. At the very
end of the simulation, caspase-3 activity reached a very
low level due to caspase-3 degradation and a reduction
in levels of pro-caspase-3.
After exposure to apoptosis stimuli, pro-caspase-3 is
cleaved to produce caspase-3, which is rapidly degraded.
As result, pro-caspase-3 can be consumed even when
stimuli are weak. In our model, a straightforward
approach obtains the following prediction: If a cell is
initially exposed to low levels of TNF signaling for a few
hours, the pool of available pro-caspase-3 will be con-
sumed. If high levels of TNF stimulation then subse-
quently occur, caspase-3 activity will not be as high as it
would be in cells that were treated with high levels of
TNF stimuli. The prediction is shown by Figure 4 with
simulation time course of caspase-3 activity and rate
of apoptosis in accordance with the treatment of a
cell with 0.1 nM FasL for 10 h, followed by 2.0 nM FasL
for 20 h.
A plateau in the apoptosis rate of cells exposed to
apoptosis stimuli
The apoptosis rate of cells following exposure to apop-
tosis stimuli is an important parameter in the study of
cell’s response to apoptosis signaling. To determine the
time dependence of a cell’s apoptosis rate, Jurkat cells
were treated with 50ng/ml TARIL, and apoptosis was
monitored. The experimental methods and results are
shown by Figure S1 in Additional file 1 , and model
simulations are shown in Figure 5.
In Figure 5, the apoptosis rates were obtained according
to Eq. 2 and Eq. 3. TRAIL (Apo-2) is a member of the
TNF family, and uses a similar mechanism as FasL to
induce apoptosis [22-24]. Therefore, we used the same
parameters listed in Table 1 to mimic the effect of
TRAIL treatment, however, the parameters in Eq. 2 and
Eq. 3 were adjusted to fit the observed apoptosis rates
(Fig. 5A). From simulations, the cell apoptosis rate was
observed to plateau after cells were exposed to apoptosis
ligands (Fig. 5A, inset). In later stages, the cell apoptosis
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Figure 4 Model simulation results for a model prediction The model simulation results obtained for a cell is stimulated with a low apoptosis
signal (i.e., 0.1nM FasL) for 10 h, followed by high apoptosis signal (i.e., 2.0nM FasL). (A) Time course of caspase-3 activity. (B). Time course of the
apoptosis rate.
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Page 7 of 10rate dropped to basal level due to a decrease in caspase-
3 activity.
We also examined the response of Jurkat cells to dif-
ferent concentrations of TNF stimuli. Simulations show
that Jurkat cells were observed to be sensitive to the sti-
muli, even when ligand concentrations were low (Fig.
5B). This appears to be in good agreement with pre-
viously reported experimental data [25].
Caspase activation efficiencies are important for cell fate
determination
Effectiveness and resistance are two important proper-
ties of an apoptosis response. To quantitatively analyze
these properties, we defined the effective and resistance
coefficients of a cell as follows, and demonstrate that
they depend on the efficiency of caspase activation.
First, the average half-lifetime (T1/2)o fc e l l si st h e
time it takes for the proportion of surviving cells to be
reduced by 50%. We assigned T0 to be the average half-
lifetime of cells in the absence of an apoptosis stimulus.
Correspondingly, the relative half-lifetime T1/2/T0 mea-
sures the decrease in cell life time that occurs in the
presence of apoptosis signaling.
The effective coefficient (EC) measures the ability of a
cell to trigger the death program when the apoptotic
initiator signal is strong. Therefore, in the case of FasL-
induced apoptosis, we define the EC as the relative half-
lifetime that is exhibited in the presence of 100ng/ml
FasL (i.e., [TNF] = 2.0nM in the model):
EC = (T1/2/T0)|[TNF]=2.0. (12)
For this definition, a smaller EC represents a more
effective response to apoptosis signals.
The resistance coefficient (RC) measures the ability of
a cell to resist minor apoptosis signals, and is defined as
the change in the relative half-life time when there are
minor apoptosis signals as follow:
RC = -(∂T1/2/∂[TNF])/T0|[TNF]=0. (13)
T h en e g a t i v es i g ne n s u r e st h a tap o s i t i v er e s i s t a n c e
coefficient will be obtained, and a smaller RC value
represents better resistance.
It is important for a cell tos i m u l t a n e o u s l ye x h i b i t
good resistance and effectiveness. However, this is not
always possible since good effectiveness (i.e., a low EC
value) usually implies bad resistance (i.e., a high RC
value) (see Figure S2 in Additional file S2 in the Supple-
mental Materials for simulation results).
To gain insight into how different coefficients in our
model affect a cell’s response, the dependencies of RC
and EC on activation efficiencies were investigated as
shown in Figure 6. These results show that as activation
efficiencies increases, so does resistance, yet effectiveness
decreases. These results suggest that the activation effi-
ciencies need to be well-adjusted in order to ensure a
cell’s proper response to apoptosis signals, i.e., small
values for both RC and EC.
In the present model, according to Eq. 10-11, activa-
tion efficiencies are determined by degradation rates and
the coefficients Ki(i =1 ,2 ,3 ) .B i o l o g i c a l l y ,t h e s ep a r a -
meters are associated with a family of genes that encode
potent caspase inhibitors known as inhibitor-of-
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Figure 5 Simulation results for cell apoptosis (fa(t)) (A) Time course for the cell apoptosis induced in Jurkat cells following exposure to 50ng/ml
TRAIL. The control time point in the experiment corresponds to 3 h at the simulation. Experimental data were analyzed using a FACSCalibur flow
cytometer (Figure S1 in the Supplemental Material). The inset shows the time course for the apoptosis rate. (B) Simulation results of cell apoptosis for
Jurkat cells incubated with increasing concentrations of death stimuli 16 h. Experimental data were retrieved from [25], Fig. 5. The parameters used
included: rpro =0 ,r0 =3 . 3 1×1 0
-6s
-1, τd =1 1 h r ,p = 1.05 × 10
-8s
-1, K4 = 55.00nM, n = 4.0, and [TNF] = 1.0nM to mimic 50 ng/ml TRAIL. The proliferation
rate was assumed to be zero based on the arrest of cell proliferation observed during the experimental period.
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Page 8 of 10apoptosis (IAP) proteins [13,26-29]. For instance, the
parameters K1 and K2 relate to the inhibition of apopto-
sis by cFLIP which directly inhibits the activation of cas-
pase-8 by competing with pro-caspase-8 for binding to
FADD [6,14,30,31]. In additional, K3 represents the
modulation of caspase-3 activation that is mediated by a
mitochondrial pathway involving Bcl-2 family members
[3,6,12]. Correspondingly, overexpression of cFILP or
Bcl-2 have been shown to block CD95-induced apopto-
sis [6]. However, further studies are needed to clarify
the effect of these parameters on the cellular response
to apoptosis signals.
Conclusions
In this paper, a simplified mathematical model of TNF-
induced apoptosis was developed based on the Fas-signal-
ing pathway proposed by Hua et al. [12] and Okazaki et al.
[14]. Our model exclude most of the detailed reactions
involved, include rapid degradation of caspase-8 and cas-
pase-3, and was focusing on the activation of these two
caspases in response to TNF stimuli. Rapid degradation of
caspase-3 has previously been reported [18], but this was
not considered in the model by Hua et al. [12]. According
to our model, a cell shown a pulse increase in caspase acti-
vations after exposure to apoptosis stimuli, and this was
because of the rapid degradation of these caspases after
being induced. This result is in contrast with the proper-
ties of bistable steady states which have been suggested by
other models [2,9,13]. However, our results agree qualita-
tively with experimental data [6,17,21]. As such, our
model indicates that a pulse increase in caspase-3 activity
is sufficient to trigger the irreversible apoptosis response.
Moreover, the dynamic properties of these cell signaling
pathways suggest that the timing of cell signaling is also
an important aspect of inducing apoptosis. Correspond-
ingly, the timing of cell signaling has been implicated in
experiments of p53-induced apoptosis [16,20]. Overall, a
phenomenological cumulative relationship between the
rate of cellular apoptosis and caspase-3 activation is
proposed, and is in good agreement with experiment data.
In this paper, we also defined the EC and RC of a cell in
order to facilitate the quantitative analysis of a cell’s
response to apoptosis signals. In this study, caspase activa-
tions was found to be essential for the effectiveness and
resistance of a cell. In addition, we proposed quantitative
definitions to represent the activation efficiencies of cas-
pase-8 and caspase-3 in terms of protein degradation rates
and model parameters that are related to the activation of
apoptosis inhibitors. Our results suggest that caspase acti-
vation efficiencies can be regulated by inhibitors such as
X-linked inhibitor of apoptosis protein (XIAP), cFLIP and
Bcl-2 family members, which have been shown to be
essential for the apoptosis pathway. Additional studies will
be needed to further investigate the regulation of apoptosis
inhibitors in the apoptosis pathway.
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